Advances and Prospects of Prolamine Corn Protein Zein as Promising Multifunctional Drug Delivery System for Cancer Treatment
Xi Luo,Sudan Wu,Meng Xiao,Huan Gu,Huan Zhang,Jianping Chen,Yang Liu,Chen Zhang,Jinming Zhang
DOI: https://doi.org/10.2147/IJN.S402891
IF: 7.033
2023-05-15
International Journal of Nanomedicine
Abstract:Xi Luo, 1, &ast Sudan Wu, 2, &ast Meng Xiao, 1 Huan Gu, 1 Huan Zhang, 1 Jianping Chen, 3 Yang Liu, 4 Chen Zhang, 1 Jinming Zhang 1 1 State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China; 2 Blood Purification Center, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China; 3 Lika Shing Faculty of Medicine, School of Chinese Medicine, the University of Hong KOng, Hong Kong, People's Republic of China; 4 Department of Vascular Surgery, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yang Liu, Hospital of Chengdu University of Traditional Chinese Medicine, No. 37, Shierqiao Road, Jinniu District, Chengdu, Sichuan, People's Republic of China, Email zjob Jinming Zhang, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, No.1166, Liutai Avenue, Wenjiang District, Chengdu, Sichuan, People's Republic of China, Email Zein is a type of prolamine protein that is derived from corn, and it has been recognized by the US FDA as one of the safest biological materials available. Zein possesses valuable characteristics that have made it a popular choice for the preparation of drug carriers, which can be administered through various routes to improve the therapeutic effect of antitumor drugs. Additionally, zein contains free hydroxyl and amino groups that offer numerous modification sites, enabling it to be hybridized with other materials to create functionalized drug delivery systems. However, despite its potential, the clinical translation of drug-loaded zein-based carriers remains challenging due to insufficient basic research and relatively strong hydrophobicity. In this paper, we aim to systematically introduce the main interactions between loaded drugs and zein, administration routes, and the functionalization of zein-based antitumor drug delivery systems, in order to demonstrate its development potential and promote their further application. We also provide perspectives and future directions for this promising area of research. Graphical Keywords: zein, nanomedicine, drug delivery, antitumor Graphical Cancer is a growing concern globally, with an estimated 19.3 million new cases and 10 million cancer-related deaths reported in 2020 alone. Unfortunately, the situation may worsen in the future, with projections indicating a 47% rise in global cancer cases by 2040, to reach 28.4 million. 1 Currently, various therapeutic approaches are employed to treat cancer, including chemotherapy, surgery, and radiotherapy. 2 While chemotherapy remains the primary treatment for cancer, it comes with several drawbacks. Although it can improve the survival and quality of life for cancer patients, it also affects blood-forming cells in the bone marrow, hair follicles, and cells in the digestive tract and reproductive system. 3,4 Nanoparticle technology is a promising new approach for cancer therapy, offering several advantages over traditional methods. For one, it can improve the bioavailability of insoluble drugs, control drug release, and reduce side effects. 5,6 Additionally, nanoparticles can passively target cancer cells thanks to the enhanced permeability and retention (EPR) effect, which leads to increased accumulation of drug-loaded particles within tumors. 7 Recent studies, however, have shown that nanoparticles primarily enter tumors through endothelial cells, rather than through gaps between them. 8 Although nanoparticles are typically administered intravenously, there are now oral and pulmonary-inhalation methods available, which can improve patient compliance. 9,10 To enhance the effectiveness of nanoparticle-based therapies, researchers have designed functionalized nanoparticles that can precisely deliver drugs to cancer cells based on the unique characteristics of the tumor microenvironment. These nanoparticles can be engineered to be pH-sensitive or GSH-sensitive, or to target highly expressed receptors on the tumor surface. 11–13 Nanoparticles can combine phototherapy, chemotherapy, and immunotherapy to further inhibit drug resistance and tumor cell migration. 14 Overall, nanoparticle technology offers a promising new approach to cancer therapy, with the potential to improve patient outcomes and reduce side effects. In the past few years, researchers have explored a -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology